Formononetin and high concentrations of biochanin A have exhibited inhibitory effects on human breast cancer cells, while calycosin and low doses of biochanin A have exhibited stimulatory effects on the proliferation of breast cells through an estrogen receptor dependent mechanism [20]. The gene discussed is ESR1; the disease is breast carcinoma.